PATENT CLAIM ANALYSIS

Application Number: 16107087
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "064000"]

Abstract:
Compounds according to Formula I are potent inhibitors of Arginase I and II activity: where R 1 , R 2 , R 3 , R 4 , D, W, X, Y, and Z are defined in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use in treating or preventing a disease or a condition associated with arginase activity.

Claim (Index 54):
The compound according to  claim 53 , wherein\n R\u2032\u2033 is selected from \u2014C(O)(C 1 -C 6 )alkyl, \u2014C(O)(C 3 -C 14 )aryl, \u2014C(O)O(C 1 -C 6 )alkyl, \u2014C(O)O(C 3 -C 14 )aryl, and \u2014C(O)(C 3 -C 14 )heterocycloalkyl, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 96.0
- Lexical Diversity: 1.44
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15207902', '13276806', '14614115', '14471244', '15972996']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7909422680551191
- 35 USC 102 Novelty (BERT): 0.5600081155867934
- Combined Prediction Score: 0.7678488528082865
- Mean Citation Score: 401.323864
- Max Citation Score: 423.62912
- Similarity Product: 339.92894149154665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test